Search

everythinglearnresearchcommunity

for

Search:↓

Nail changes are common in alopecia areata and can indicate its severity.

Children with alopecia areata have lower BDNF levels, linked to worse symptoms and quality of life.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Higher antigliadin antibody levels are linked to alopecia areata severity.

The MPV/PC ratio can help assess disease activity in alopecia areata.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

Low vitamin D levels are common in people with Alopecia Areata.

Alopecia areata patients may have higher T3 and cortisol levels, suggesting a hormonal link.

The Brigham Eyelash Tool for Alopecia (BELA) is a reliable way to measure eyelash loss in alopecia areata patients.

Carcinosin, a homeopathic remedy, helped a young girl with alopecia areata regrow hair and reduce psychological symptoms.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

How bad a woman's hair loss is doesn't always match how it affects her happiness and daily life.

Children with alopecia areata in Singapore generally have a good quality of life.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib may help treat severe hair loss, but more research is needed.

Baricitinib is effective and safe for treating severe alopecia areata.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

The combination of calcipotriol and PRP is the most effective treatment for alopecia areata.

miR-155-5p can help diagnose and track alopecia areata severity.